Published in Eur J Heart Fail on October 31, 2014
Race-Related Differences in Left Ventricular Structural and Functional Remodeling in Response to Increased Afterload: The ARIC Study. JACC Heart Fail (2016) 0.75
Normal age-related changes in left ventricular function: Role of afterload and subendocardial dysfunction. Int J Cardiol (2016) 0.75
Association of Systemic Arterial Properties With Right Ventricular Morphology: The Multi-Ethnic Study of Atherosclerosis (MESA)-Right Ventricle Study. J Am Heart Assoc (2016) 0.75
Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation (2000) 10.25
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation (2007) 3.78
Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation (2005) 3.34
Left ventricular interaction with arterial load studied in isolated canine ventricle. Am J Physiol (1983) 2.91
Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA (2011) 2.86
Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the Multi-Ethnic Study of Atherosclerosis. Circ Cardiovasc Imaging (2009) 2.51
Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol (2009) 2.34
Impact of arterial load and loading sequence on left ventricular tissue velocities in humans. J Am Coll Cardiol (2007) 2.05
Arterial properties as determinants of time-varying myocardial stress in humans. Hypertension (2012) 1.86
Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study. Circulation (2010) 1.62
Impact of arterial stiffening on left ventricular structure. Hypertension (2000) 1.62
Relaxation and diastole of the heart. Physiol Rev (1989) 1.61
Association of cardiorespiratory fitness with left ventricular remodeling and diastolic function: the Cooper Center Longitudinal Study. JACC Heart Fail (2014) 1.54
Different role of wave reflection magnitude and timing on left ventricular mass reduction during antihypertensive treatment. J Hypertens (2008) 1.40
Assessment of diastolic dysfunction. Invasive modalities. Cardiol Clin (2000) 1.39
Influence of aortic impedance on the development of pressure-overload left ventricular hypertrophy in rats. Circulation (1996) 1.36
Exercise training increases total systemic arterial compliance in humans. Am J Physiol (1994) 1.36
Early and late systolic wall stress differentially relate to myocardial contraction and relaxation in middle-aged adults: the Asklepios study. Hypertension (2013) 1.25
Central obesity: association with left ventricular dysfunction and mortality in the community. Am Heart J (2008) 1.24
Relation of effective arterial elastance to arterial system properties. Am J Physiol Heart Circ Physiol (2002) 1.18
Longitudinal changes in left ventricular stiffness: a community-based study. Circ Heart Fail (2013) 1.09
Effect of ageing on left ventricular compliance and distensibility in healthy sedentary humans. J Physiol (2012) 1.02
Heart rate reduction by If-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction. Eur Heart J (2012) 0.96
Exercise training increases arterial compliance in patients with congestive heart failure. Clin Sci (Lond) (2002) 0.94
Use of the Frank-Starling mechanism during exercise is linked to exercise-induced changes in arterial load. Am J Physiol Heart Circ Physiol (2011) 0.89
Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients. J Am Coll Cardiol (2013) 0.87
Age-related reduction of systemic arterial compliance induces excessive myocardial oxygen consumption during sub-maximal exercise. Hypertens Res (2006) 0.80
Influence of arterial compliance on presence and extent of ischaemia during stress echocardiography. Heart (2006) 0.80
Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med (2006) 17.13
Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA (2003) 13.79
Diuretic strategies in patients with acute decompensated heart failure. N Engl J Med (2011) 11.99
Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol (2004) 8.97
Trends in heart failure incidence and survival in a community-based population. JAMA (2004) 8.90
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet (2006) 8.61
Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med (2012) 8.28
Systolic and diastolic heart failure in the community. JAMA (2006) 5.99
Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol (2005) 5.39
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. N Engl J Med (2015) 4.39
Cardiac safety analysis of doxorubicin and cyclophosphamide followed by paclitaxel with or without trastuzumab in the North Central Cancer Treatment Group N9831 adjuvant breast cancer trial. J Clin Oncol (2008) 4.24
Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol (2009) 4.16
Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA (2005) 3.89
Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation (2007) 3.78
Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol (2002) 3.68
Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction. J Am Coll Cardiol (2010) 3.63
Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med (2006) 3.59
Hospitalizations after heart failure diagnosis a community perspective. J Am Coll Cardiol (2009) 3.42
Age- and gender-related ventricular-vascular stiffening: a community-based study. Circulation (2005) 3.34
Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction. Circulation (2013) 3.28
Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc (2007) 3.12
Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction. Circulation (2006) 3.01
Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail (2010) 3.01
Assessing adiposity: a scientific statement from the American Heart Association. Circulation (2011) 3.00
Pulmonary pressures and death in heart failure: a community study. J Am Coll Cardiol (2012) 2.98
Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA (2011) 2.86
Unexplained pulmonary hypertension in elderly patients. Chest (2007) 2.85
Immunoreactivity and guanosine 3',5'-cyclic monophosphate activating actions of various molecular forms of human B-type natriuretic peptide. Hypertension (2007) 2.77
Sex differences in arterial stiffness and ventricular-arterial interactions. J Am Coll Cardiol (2012) 2.74
Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res (2008) 2.73
Agreement between patient reports of cardiovascular disease and patient medical records. Mayo Clin Proc (2005) 2.71
Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J (2009) 2.71
Age-associated increases in pulmonary artery systolic pressure in the general population. Circulation (2009) 2.70
Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol (2005) 2.69
Left atrial volume as an index of left atrial size: a population-based study. J Am Coll Cardiol (2003) 2.62
Combining body mass index with measures of central obesity in the assessment of mortality in subjects with coronary disease: role of "normal weight central obesity". J Am Coll Cardiol (2013) 2.61
Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J Am Coll Cardiol (2006) 2.61
Epidemiology of diastolic heart failure. Prog Cardiovasc Dis (2005) 2.59
Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol (2009) 2.53
Longitudinal changes in ejection fraction in heart failure patients with preserved and reduced ejection fraction. Circ Heart Fail (2012) 2.53
Central obesity and survival in subjects with coronary artery disease: a systematic review of the literature and collaborative analysis with individual subject data. J Am Coll Cardiol (2011) 2.50
Death in heart failure: a community perspective. Circ Heart Fail (2008) 2.46
Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation. Circulation (2007) 2.43
Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. J Am Coll Cardiol (2012) 2.41
Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans. Circulation (2005) 2.38
Diagnostic performance of body mass index to detect obesity in patients with coronary artery disease. Eur Heart J (2007) 2.38
Limitations of estimating glomerular filtration rate from serum creatinine in the general population. Mayo Clin Proc (2006) 2.37
Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction. J Am Coll Cardiol (2009) 2.34
Normal-Weight Central Obesity: Implications for Total and Cardiovascular Mortality. Ann Intern Med (2015) 2.31
Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study. Circ Heart Fail (2012) 2.26
The national cholesterol education program diet vs a diet lower in carbohydrates and higher in protein and monounsaturated fat: a randomized trial. Arch Intern Med (2004) 2.24
Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA (2009) 2.10
Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med (2006) 2.09
Impact of arterial load and loading sequence on left ventricular tissue velocities in humans. J Am Coll Cardiol (2007) 2.05
Incidence of heart failure after myocardial infarction: is it changing over time? Am J Epidemiol (2003) 2.03
Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension. J Hypertens (2007) 2.01
Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation (2011) 2.00
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol (2006) 1.98
Functional impact of rate irregularity in patients with heart failure and atrial fibrillation receiving cardiac resynchronization therapy. Eur Heart J (2004) 1.95
Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation (2011) 1.92
Ventricular-arterial coupling, remodeling, and prognosis in chronic heart failure. J Am Coll Cardiol (2013) 1.86
Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med (2008) 1.84
Acute and chronic reduction of functional mitral regurgitation in experimental heart failure by percutaneous mitral annuloplasty. J Am Coll Cardiol (2004) 1.82
Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest (2010) 1.79
Diastolic and systolic heart failure are distinct phenotypes within the heart failure spectrum. Circulation (2011) 1.78
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78
Use of a novel ultrafiltration device as a treatment strategy for diuretic resistant, refractory heart failure: initial clinical experience in a single center. J Card Fail (2006) 1.77
Heart failure after myocardial infarction: a review. Am J Med (2002) 1.76
Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation (2007) 1.72
Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time. Circulation (2007) 1.69
ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects. Eur Heart J (2007) 1.67
Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study. Circulation (2004) 1.67
Novel protein therapeutics for systolic heart failure: chronic subcutaneous B-type natriuretic peptide. J Am Coll Cardiol (2012) 1.66
Relationships between right ventricular function, body composition, and prognosis in advanced heart failure. J Am Coll Cardiol (2013) 1.65
Prognostic value of biomarkers in heart failure: application of novel methods in the community. Circ Heart Fail (2009) 1.62
Differentiating between body fat and lean mass-how should we measure obesity? Nat Clin Pract Endocrinol Metab (2008) 1.61
Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol (2012) 1.61
Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP. J Am Coll Cardiol (2012) 1.61